文献速递胰腺与胆道疾病消化内镜

腹腔镜辅助内镜逆行胰胆管造影在Roux-en-Y胃旁路术患者中临床实用性的多中心评价

Multicenter evaluation of the clinical utility of laparoscopy-assisted ERCP in patients with Roux-en-Y gastric bypass.
PubMed 文献 · Gastrointest Endosc · 2017-11-10

本研究为34个中心回顾性队列,纳入579例Roux-en-Y胃旁路术(RYGB)成人患者,评估腹腔镜辅助内镜逆行胰胆管造影(LA-ERCP)的可行性、安全性和结局。手术成功率达98%,总手术时间中位152分钟,住院中位2天,不良事件发生率18%(腹腔镜相关10%、ERCP相关7%、两者兼有1%),其中92%为轻中度、8%为重度、1例死亡。结论认为LA-ERCP在RYGB患者中可行且成功率高,ERCP相关不良事件率与传统ERCP相当,但总不良事件率因腹腔镜相关事件而更高。

要点

  • LA-ERCP在RYGB患者中手术成功率达98%,中位总手术时间152分钟、ERCP时间40分钟、住院2天。
  • 不良事件发生率18%,其中腹腔镜相关10%、ERCP相关7%、两者兼有1%,92%为轻中度、8%为重度、1例死亡。
  • 作者结论认为LA-ERCP在RYGB患者中可行且成功率高,ERCP相关不良事件率与传统ERCP相当,总不良事件率因腹腔镜相关事件而更高。

核心结论

  • 这项大型多中心研究表明,LA-ERCP在RYGB患者中可行,手术成功率高,与正常解剖患者的标准ERCP相当。
  • ERCP相关不良事件率与传统ERCP相当,但总不良事件率因附加的腹腔镜相关事件而更高。

研究设计与样本

  • 回顾性队列研究,纳入34个中心中接受LA-ERCP的RYGB成人患者,收集人口学、适应证、手术成功和不良事件数据。
  • 共纳入579例患者,中位年龄51岁,84%为女性;适应证为胆道89%、胰腺8%、两者兼有3%。
  • 手术成功定义为达到乳头、插管进入目标胆管并按临床指征完成内镜治疗。

主要发现

  • 手术成功率为98%。
  • 中位总手术时间152分钟(四分位距109-210),中位ERCP时间40分钟(四分位距28-56),中位住院时间2天(四分位距1-3)。
  • 不良事件发生率为18%,其中腹腔镜相关10%、ERCP相关7%、两者兼有1%;92%为轻中度,8%为重度,发生1例死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The obesity epidemic has led to increased use of Roux-en-Y gastric bypass (RYGB). These patients have an increased incidence of pancreaticobiliary diseases, yet standard ERCP is not possible because of surgically altered gastroduodenal anatomy. Laparoscopy-assisted ERCP (LA-ERCP) has been proposed as an option, but supporting data are derived from single-center small case series. Therefore, we conducted a large multicenter study to evaluate the feasibility, safety, and outcomes of LA-ERCP. METHODS: This is a retrospective cohort study of adult patients with RYGB who underwent LA-ERCP in 34 centers. Data on demographics, indications, procedure success, and adverse events were collected. Procedure success was defined when all the following were achieved: reaching the papilla, cannulating the desired duct, and providing endoscopic therapy as clinically indicated. RESULTS: A total of 579 patients (median age, 51; 84% women) were included. Indication for LA-ERCP was biliary in 89%, pancreatic in 8%, and both in 3%. Procedure success was achieved in 98%. Median total procedure time was 152 minutes (interquartile range [IQR], 109-210), with a median ERCP time of 40 minutes (IQR, 28-56). Median hospital stay was 2 days (IQR, 1-3). Adverse events were 18% (laparoscopy related, 10%; ERCP related, 7%; both, 1%) with the clear majority (92%) classified as mild/moderate, whereas 8% were severe and 1 death occurred. CONCLUSIONS: Our large multicenter study indicates that LA-ERCP in patients with RYGB is feasible with a high procedure success rate comparable with that of standard ERCP in patients with normal anatomy. The ERCP-related adverse events rate is comparable with conventional ERCP, but the overall adverse event rate was higher because of the added laparoscopy-related events.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter evaluation of the clinical utility of laparoscopy-assisted ERCP in patients with Roux-en-Y gastric bypass. Gastrointest Endosc. 2017. PMID: 29129525. doi:10.1016/j.gie.2017.10.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。